Sirtuin 3 (Sirt3) has been found to be a functional target of DHM to ameliorate HFD-induced nonalcoholic fatty liver disease (NAFLD) [11]. The gene discussed is SIRT3; the disease is metabolic dysfunction-associated steatotic liver disease.